Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Urothelial Carcinoma
Interventions
DRUG

18F-FDG

All study participants will undergo one 18F-FDG PET/CT scan.

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER